Captor Therapeutics S.A. (CTX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.346x

Based on the latest financial reports, Captor Therapeutics S.A. (CTX) has a cash flow conversion efficiency ratio of -0.346x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-11.51 Million ≈ $-3.17 Million USD) by net assets (zł33.27 Million ≈ $9.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Captor Therapeutics S.A. - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Captor Therapeutics S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Captor Therapeutics S.A. balance sheet liabilities for a breakdown of total debt and financial obligations.

Captor Therapeutics S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Captor Therapeutics S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Spir Group ASA OL:SPIR	0.103x
After You Public Company Limited BK:AU	0.100x
Nicola Mining Inc V:NIM	0.542x
Cornerstone OnDemand Inc F:8CO	0.014x
China Automotive Systems Inc F:RYV	0.075x
Tonlin Department Store Co Ltd TW:2910	0.020x
Tempore Properties SOCIMI SAU MC:YTEM	0.013x
Newcore Gold Ltd V:NCAU	0.007x

Annual Cash Flow Conversion Efficiency for Captor Therapeutics S.A. (2017–2024)

The table below shows the annual cash flow conversion efficiency of Captor Therapeutics S.A. from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Captor Therapeutics S.A. stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł64.47 Million ≈ $17.74 Million	zł-31.88 Million ≈ $-8.77 Million	-0.494x	+34.44%
2023-12-31	zł69.22 Million ≈ $19.05 Million	zł-52.20 Million ≈ $-14.37 Million	-0.754x	-216.56%
2022-12-31	zł96.32 Million ≈ $26.51 Million	zł-22.95 Million ≈ $-6.32 Million	-0.238x	-3.92%
2021-12-31	zł124.20 Million ≈ $34.18 Million	zł-28.47 Million ≈ $-7.84 Million	-0.229x	-138.68%
2020-12-31	zł-1.00 Million ≈ $-276.32K	zł-595.00K ≈ $-163.75K	0.593x	-42.31%
2019-12-31	zł4.28 Million ≈ $1.18 Million	zł4.39 Million ≈ $1.21 Million	1.027x	+265.41%
2018-12-31	zł3.43 Million ≈ $944.26K	zł-2.13 Million ≈ $-586.48K	-0.621x	-104.27%
2017-12-31	zł144.00K ≈ $39.63K	zł2.10 Million ≈ $577.12K	14.563x	--

About Captor Therapeutics S.A.

WAR:CTX Poland Biotechnology

Market Cap

$119.47 Million

zł434.09 Million PLN

Market Cap Rank

#18514 Global

#140 in Poland

Share Price

zł78.80

Change (1 day)

-2.11%

52-Week Range

zł31.40 - zł87.60

All Time High

zł202.00